GHSI: Guardion Health Sciences, Inc. Stock

by  •  • Comments Off on GHSI: Guardion Health Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.27
Enterprise Value ($M) 3.91
Book Value ($M) 8.15
Book Value / Share 6.34
Price / Book 1.26
NCAV ($M) 8.11
NCAV / Share 6.32
Price / NCAV 1.27

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 6.98
Current Ratio 9.01

Balance Sheet (mrq) ($M)
Current Assets 11.88
Assets 11.92
Liabilities 3.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12.25
Operating Income -3.94
Net Income 0.16
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.37
Cash from Investing 0.02
Cash from Financing -5.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G/A Intracoastal Capital, Llc 3.80
02-05 13G/A Hudson Bay Capital Management LP 9.99 -97.87

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 3,159 10,556 29.93
2024-05-02 705 379 186.02
2024-05-01 19 325 5.85
2024-04-29 106 841 12.60

(click for more detail)

Similar Companies
FWBI – First Wave BioPharma, Inc. GALT – Galectin Therapeutics Inc.
GDTC – CytoMed Therapeutics Limited GLMD – Galmed Pharmaceuticals Ltd.
GLSI – Greenwich LifeSciences, Inc.


Financial data and stock pages provided by
Fintel.io